Andrew Bascand: Investing in new technology

from The Weekend Collective · host Newstalk ZB

Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors. Listen in for your chance to get ahead of the markets. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Sep 17, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Andrew Bascand: Investing in new technology

0:00 40:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Weekend Collective?

This episode is 40 minutes long.

When was this The Weekend Collective episode published?

This episode was published on September 17, 2023.

Can I download this The Weekend Collective episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!